by Ian Lipman | May 19, 2022 | News
Client News OKYO Pharma Limited: Closing of Offering Home / Client News / OKYO Pharma Limited: Closing of Offering London and New York, 19 May 2022 – OKYO Pharma Limited (LSE: OKYO; Nasdaq: OKYO) (“OKYO” or the “Company”), a life sciences...
by Ian Lipman | May 18, 2022 | News
Client News OKYO Pharma Limited: Director/PDMR Shareholding Home / Client News / OKYO Pharma Limited: Director/PDMR Shareholding London and New York, NY, 18 May, 2022 – OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a biotechnology company focused on the...
by Ian Lipman | May 18, 2022 | News
Client News Eurasia Mining PLC: New Director Appointed Home / Client News / Eurasia Mining PLC: New Director Appointed Eurasia Mining Plc (“Eurasia” or the “Company”), the palladium, platinum, rhodium, iridium and gold producing company is...
by Ian Lipman | May 18, 2022 | News
Client News Zaim Credit Systems Plc: Audited financial results for the year ended 31 December 2021 Home / Client News / Zaim Credit Systems Plc: Audited financial results for the year ended 31 December 2021 Zaim Credit Systems plc (the ‘Group’ or...
by Ian Lipman | May 17, 2022 | News
Client News OKYO Pharma Limited: Announces Pricing of IPO of ADSs in the U.S. Home / Client News / OKYO Pharma Limited: Announces Pricing of IPO of ADSs in the U.S. London, May 17, 2022 – OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) (“OKYO” or the...
Recent Comments